746
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies

, , &
Pages 988-998 | Received 05 Apr 2013, Accepted 12 Jul 2013, Published online: 31 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhe (Jenny) Zhang, Peggy A Bulur, Ahmet Dogan, Dennis A Gastineau, Allan B Dietz & Yi Lin. (2015) Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance . OncoImmunology 4:4.
Read now

Articles from other publishers (6)

Sandra L. Guerrero-Rodríguez, Cecilia Mata-Cruz, Sonia M. Pérez-Tapia & Marco A. Velasco-Velázquez. (2022) Role of CD36 in cancer progression, stemness, and targeting. Frontiers in Cell and Developmental Biology 10.
Crossref
Sudjit Luanpitpong, Montira Janan, Kanjana Thumanu, Jirarat Poohadsuan, Napachai Rodboon, Phatchanat Klaihmon & Surapol Issaragrisil. (2019) Deciphering the Elevated Lipid via CD36 in Mantle Cell Lymphoma with Bortezomib Resistance Using Synchrotron-Based Fourier Transform Infrared Spectroscopy of Single Cells. Cancers 11:4, pages 576.
Crossref
Sudjit Luanpitpong, Jirarat Poohadsuan, Parinya Samart, Chayanin Kiratipaiboon, Yon Rojanasakul & Surapol Issaragrisil. (2018) Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:11, pages 3739-3753.
Crossref
Alexandra Smith, Eve Roman, Simon Appleton, Debra Howell, Rod Johnson, Cathy Burton & Russell Patmore. (2018) Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK 's Haematological Malignancy Research Network ( HMRN ) . British Journal of Haematology 181:2, pages 215-228.
Crossref
Hun Ju Lee, Jorge E. Romaguera, Lei Feng, Aakash P. Desai, Liang Zhang, Michelle Fanale, Felipe Samaniego, Fredrick B. Hagemeister, Luis E. Fayad, Maria A. Rodriguez, Jeffrey L. Medeiros, Kimberly Hartig, Krystle Nomie, Makhdum Ahmed, Maria Badillo, Haige Ye, Yasuhiro Oki, Pei Lin, Loretta Nastoupil, Jason Westin & Michael Wang. (2017) Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma. The Oncologist 22:5, pages 549-553.
Crossref
Rohit Mathur, Lalit Sehgal, Frank K. Braun, Zuzana Berkova, Jorge Romaguerra, Michael Wang, M. Alma Rodriguez, Luis Fayad, Sattva S. Neelapu & Felipe Samaniego. (2015) Targeting Wnt pathway in mantle cell lymphoma-initiating cells. Journal of Hematology & Oncology 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.